U.S. FDA Cuts Gap For Moderna COVID-19 Booster Dose To Five Months
On friday, the U.S. Food and Drug Administration shortened from at least five months to a month the interval between primary series and boosters of
On friday, the U.S. Food and Drug Administration shortened from at least five months to a month the interval between primary series and boosters of
